253 related articles for article (PubMed ID: 30417317)
1. Guanosine Protects Striatal Slices Against 6-OHDA-Induced Oxidative Damage, Mitochondrial Dysfunction, and ATP Depletion.
Marques NF; Massari CM; Tasca CI
Neurotox Res; 2019 Feb; 35(2):475-483. PubMed ID: 30417317
[TBL] [Abstract][Full Text] [Related]
2. Adenosine A
Massari CM; Constantino LC; Tasca CI
Purinergic Signal; 2021 Jun; 17(2):247-254. PubMed ID: 33548045
[TBL] [Abstract][Full Text] [Related]
3. In vitro 6-hydroxydopamine-induced toxicity in striatal, cerebrocortical and hippocampal slices is attenuated by atorvastatin and MK-801.
Massari CM; Castro AA; Dal-Cim T; Lanznaster D; Tasca CI
Toxicol In Vitro; 2016 Dec; 37():162-168. PubMed ID: 27647473
[TBL] [Abstract][Full Text] [Related]
4. Guanosine prevents depressive-like behaviors in rats following bilateral dorsolateral striatum lesion induced by 6-hydroxydopamine.
Marques NF; Binder LB; Roversi K; Sampaio TB; Constantino LC; Prediger RD; Tasca CI
Behav Brain Res; 2019 Oct; 372():112014. PubMed ID: 31212060
[TBL] [Abstract][Full Text] [Related]
5. 6-Hydroxydopamine induces different mitochondrial bioenergetics response in brain regions of rat.
Gonçalves DF; Courtes AA; Hartmann DD; da Rosa PC; Oliveira DM; Soares FAA; Dalla Corte CL
Neurotoxicology; 2019 Jan; 70():1-11. PubMed ID: 30359634
[TBL] [Abstract][Full Text] [Related]
6. Purinergic Antagonism Prevents Mitochondrial Dysfunction and Behavioral Deficits Associated with Dopaminergic Toxicity Induced by 6-OHDA in Rats.
Kumar S; Mishra A; Krishnamurthy S
Neurochem Res; 2017 Dec; 42(12):3414-3430. PubMed ID: 28836128
[TBL] [Abstract][Full Text] [Related]
7. Guanosine controls inflammatory pathways to afford neuroprotection of hippocampal slices under oxygen and glucose deprivation conditions.
Dal-Cim T; Ludka FK; Martins WC; Reginato C; Parada E; Egea J; López MG; Tasca CI
J Neurochem; 2013 Aug; 126(4):437-50. PubMed ID: 23713463
[TBL] [Abstract][Full Text] [Related]
8. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A
Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146
[TBL] [Abstract][Full Text] [Related]
9. Involvement of adenosine triphosphate-sensitive potassium channels in the neuroprotective activity of hydrogen sulfide in the 6-hydroxydopamine-induced animal model of Parkinson's disease.
Sarookhani MR; Haghdoost-Yazdi H; Sarbazi-Golezari A; Babayan-Tazehkand A; Rastgoo N
Behav Pharmacol; 2018 Jun; 29(4):336-343. PubMed ID: 29239973
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress and dopamine depletion in an intrastriatal 6-hydroxydopamine model of Parkinson's disease.
Smith MP; Cass WA
Neuroscience; 2007 Feb; 144(3):1057-66. PubMed ID: 17110046
[TBL] [Abstract][Full Text] [Related]
11. Guanosine protects against Ca
Courtes AA; de Carvalho NR; Gonçalves DF; Hartmann DD; da Rosa PC; Dobrachinski F; Franco JL; de Souza DOG; Soares FAA
Biomed Pharmacother; 2019 Mar; 111():1438-1446. PubMed ID: 30841459
[TBL] [Abstract][Full Text] [Related]
12. Dimethyl fumarate attenuates 6-OHDA-induced neurotoxicity in SH-SY5Y cells and in animal model of Parkinson's disease by enhancing Nrf2 activity.
Jing X; Shi H; Zhang C; Ren M; Han M; Wei X; Zhang X; Lou H
Neuroscience; 2015 Feb; 286():131-40. PubMed ID: 25449120
[TBL] [Abstract][Full Text] [Related]
13. Guanosine protects glial cells against 6-hydroxydopamine toxicity.
Giuliani P; Ballerini P; Buccella S; Ciccarelli R; Rathbone MP; Romano S; D'Alimonte I; Caciagli F; Di Iorio P; Pokorski M
Adv Exp Med Biol; 2015; 837():23-33. PubMed ID: 25310956
[TBL] [Abstract][Full Text] [Related]
14. JM-20 protects against 6-hydroxydopamine-induced neurotoxicity in models of Parkinson's disease: Mitochondrial protection and antioxidant properties.
Fonseca-Fonseca LA; da Silva VDA; Wong-Guerra M; Ramírez-Sánchez J; Yaquis ASP; Ochoa-Rodríguez E; Verdecia-Reyes Y; de Araújo FM; Santana RC; Outeiro TF; Costa SL; Núñez-Figueredo Y
Neurotoxicology; 2021 Jan; 82():89-98. PubMed ID: 33232743
[TBL] [Abstract][Full Text] [Related]
15. Carvacrol Protects Against 6-Hydroxydopamine-Induced Neurotoxicity in In Vivo and In Vitro Models of Parkinson's Disease.
Manouchehrabadi M; Farhadi M; Azizi Z; Torkaman-Boutorabi A
Neurotox Res; 2020 Jan; 37(1):156-170. PubMed ID: 31364033
[TBL] [Abstract][Full Text] [Related]
16. Dopamine receptor activation mitigates mitochondrial dysfunction and oxidative stress to enhance dopaminergic neurogenesis in 6-OHDA lesioned rats: A role of Wnt signalling.
Mishra A; Singh S; Tiwari V; Chaturvedi S; Wahajuddin M; Shukla S
Neurochem Int; 2019 Oct; 129():104463. PubMed ID: 31078578
[TBL] [Abstract][Full Text] [Related]
17. Coenzyme Q10 Prevents Mitochondrial Dysfunction and Facilitates Pharmacological Activity of Atorvastatin in 6-OHDA Induced Dopaminergic Toxicity in Rats.
Prajapati SK; Garabadu D; Krishnamurthy S
Neurotox Res; 2017 May; 31(4):478-492. PubMed ID: 28130746
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
19. Probucol modulates oxidative stress and excitotoxicity in Huntington's disease models in vitro.
Colle D; Hartwig JM; Soares FA; Farina M
Brain Res Bull; 2012 Mar; 87(4-5):397-405. PubMed ID: 22245028
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the antiparkinsonism and neuroprotective effects of hydrogen sulfide in acute 6-hydroxydopamine-induced animal model of Parkinson's disease: behavioral, histological and biochemical studies.
Sarukhani M; Haghdoost-Yazdi H; Sarbazi Golezari A; Babayan-Tazehkand A; Dargahi T; Rastgoo N
Neurol Res; 2018 Jul; 40(7):523-531. PubMed ID: 29726751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
